उत्पाद वर्णन
Description
- Each Uncoated Bilayered tablet contains : Metformin Hydrochloride IP 500 mg.(Extended Release Form) Glimepiride IP 2 mg. Voglibose IP 0.3 mg.
Indication
- Glimepiride+Metformin+Voglibose is a combination of three medicines: Glimepiride, Metformin and Voglibose. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves the blood glucose levels in adults when taken along with proper diet and regular exercise.
Optimized Triple-Action Diabetes ManagementThis innovative medication merges Metformin, Glimepiride, and Voglibose, addressing various mechanisms of blood glucose regulation. Its extended-release formulation offers consistent efficacy and improved patient compliance, making it a practical addition to any professional pharmaceutical portfolio.
Perfect for B2B Distribution ChannelsManufactured to meet high industry standards, these tablets cater to dealers, wholesalers, and exporters who require reliable supply chains. The product's one-year shelf life and compact packaging enhance logistics management for Indian distributors, retailers, and pharmacies.
FAQ's of Metformin Hydrochloride IP 500 mg.(Extended Release Form) Glimepiride IP 2 mg. Voglibose IP 0.3 mg.:
Q: How should Metformin Hydrochloride IP 500 mg, Glimepiride IP 2 mg, Voglibose IP 0.3 mg tablets be stored?
A: These tablets should be stored in a cool place, away from direct sunlight and moisture, to maintain their stability and effectiveness throughout the one-year shelf life.
Q: What are the key ingredients and their purposes in this product?
A: The product contains Metformin Hydrochloride (improves insulin sensitivity), Glimepiride (stimulates insulin release), and Voglibose (delays glucose absorption), providing synergistic blood sugar control.
Q: When is this combination therapy generally recommended for use?
A: This combination is commonly prescribed to adults with type 2 diabetes when single-drug therapy does not achieve adequate glycemic control, always under medical supervision.
Q: Where is this medication primarily distributed and who can purchase it?
A: It is widely distributed across India and available for purchase by licensed dealers, distributors, wholesalers, manufacturers, and pharmacies operating in the B2B pharmaceutical sector.
Q: What is the process for importing or wholesaling this product in India?
A: Interested parties should have the necessary pharmaceutical distribution licenses and comply with Indian regulatory guidelines before importing or wholesaling the tablets.
Q: How do these tablets benefit B2B partners in the pharmaceutical supply chain?
A: The extended-release, combination formula reduces inventory complexity, enhances patient outcomes, and offers a stable, water-soluble product, making it ideal for efficient wholesale and retail operations.